Abbott Hits Teva With Another Suit Over Generic Simcor
Abbott Laboratories has stepped up its patent infringement battle against generic-drug maker Teva Pharmaceutical Industries Ltd. over efforts to introduce a copycat version of cholesterol treatment Simcor....To view the full article, register now.
Already a subscriber? Click here to view full article